Table 3 Comorbidity in soft tissue sarcoma patients (N = 1246) and the general comparison cohort (N = 6230) before diagnosis/index date according to the Charlson Comorbidity Index
From: Relative mortality in soft tissue sarcoma patients: a Danish population-based cohort study
Condition | STS patients N (%) | General population cohort N (%) | P-value†|
|---|---|---|---|
Myocardial infarct | 44 (3.5) | 188 (3.0) | 0.34 |
Congestive heart failure | 22 (1.8) | 133 (1.8) | 0.91 |
Peripheral vascular disease | 27 (2.2) | 100 (1.6) | 0.16 |
Cerebrovascular disease | 44 (3.5) | 259 (4.2) | 0.31 |
Dementia | 5 (0.4) | 39 (0.6) | 0.34 |
Chronic pulmonary disease | 47 (3.8) | 259 (4.2) | 0.53 |
Connective tissue disease | 18 (1.4) | 97 (1.6) | 0.77 |
Ulcer disease | 37 (3.0) | 167 (2.7) | 0.57 |
Mild liver disease | 7 (0.6) | 31 (0.5) | 0.77 |
Diabetes | 33 (2.7) | 164 (2.6) | 0.97 |
Hemiplegia | 1 (0.1) | 4 (0.1) | 0.84 |
Moderate/severe renal disease | 11 (0.9) | 39 (0.6) | 0.31 |
Diabetes with end organ damage | 7 (0.6) | 67 (1.1) | 0.10 |
Any tumour* | 121 (9.7) | 323 (5.2) | <0.001 |
Leukemia | 4 (0.3) | 9 (0.1) | 0.17 |
Lymphoma | 5 (0.4) | 14 (0.2) | 0.26 |
Moderate/severe liver disease | 0 (0.0) | 6 (0.1) | 0.27 |
Metastatic solid tumour | 32 (2.6) | 22 (0.4) | <0.001 |
AIDS | 0 (0.0) | 3 (0.1) | 0.44 |